Some of you may have recently seen articles in the newspaper or on TV about a test called OVA1. OVA1 is a test approved by the FDA which measures the levels of five proteins in blood samples from women with a known ovarian mass that have been reported to change when ovarian cancer is present. … Continued
01/29/2010 Each year, OCRF awards millions of dollars in grants to researchers who are working to beat ovarian cancer. Our two newest grantees, Dr. Lin Zhang and Dr. Kathryn Terry, each received a $200,000 renewal, which will enable them to continue their work. Lin Zhang, MD Research Assistant Professor University of Pennsylvania School of Medicine … Continued
11/17/2009 The Board of Directors of the Ovarian Cancer Research Fund (OCRF) is pleased to announce that Jeff Boyd, PhD, Chief Scientific Officer at the Fox Chase Cancer Center in Philadelphia, PA, has been appointed Chair of the OCRF Scientific Advisory Committee (SAC). The Scientific Advisory Committee is charged with evaluating research proposals to ensure … Continued
03/17/2009 Today, the Ovarian Cancer Research Fund (OCRF) announced its most recent research grant recipients. Grants were awarded in three different categories: the Program Project Development Grant, the Liz Tilberis Award, and the Ovarian Cancer Research Training Program of Excellence. The grants, awarded to seventeen researchers at twelve research institutions, totaled over 5 million dollars. … Continued
On February 5, 2009, OCRF, in partnership with the Gynecologic Cancer Foundation (GCF), announced that Barbara Goff, M.D., Director of Gynecologic Oncology at the University of Washington, has been named to lead the OCRF Ovarian Cancer Symptoms Study. The award was presented by OCRF Scientific Advisory Board Vice-Chair, Carmel Cohen, M.D., at the Society of … Continued
OCRF Partners with GCF to Continue Ovarian Cancer Symptoms Research Gynecologic Cancer Foundation Bulletin Summer 2008
Get email updates about research news, action alerts, and ways to join the fight.
